The side effects will come back full force, Dr
In landmark trials such as SUSTAIN-6 and PIONEER-6, semaglutide demonstrated a significant reduction in major adverse cardiovascular events, including cardiovascular death, non-fatal heart attacks, and strokes, compared to placebo or standard care
In 2023, Fractyl Heath announced mice given semaglutide and treated with its gene therapy Rejuva, administered directly to the pancreas, had maintained a 22% weight loss for 28 weeks after stopping the drug and performed better than those given only semaglutide
Dietary adjustments often provide significant relief, including eating smaller, more frequent meals rather than large portions, avoiding high-fat or spicy foods that may exacerbate symptoms, and eating slowly to allow for better digestion
Individuals on GLP-1s might not regain this muscle mass when or iif they discontinue the drugs
Tirzepatide is a GLP-1 receptor agonist and GIP receptor agonist (dual incretin mimetic) that demonstrated 20% or greater weight loss in clinical trials